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ORIGINAL ARTICLE
Breathing Disturbances Without Hypoxia Are Associated With Objective 
Sleepiness in Sleep Apnea
Henriette Koch, Msc1,2,3; Logan Douglas Schneider, MD1; Laurel A. Finn, MS4; Eileen B. Leary, MS, RPSGT1; Paul E. Peppard, PhD, MS4; Erika Hagen, PhD4; 
Helge Bjarup Dissing Sorensen, PhD, MSK2; Poul Jennum, DMSc3; Emmanuel Mignot, MD, PhD1
1Department of  Psychiatry and Behavioral Medicine, Stanford University Center for Sleep Sciences and Medicine, Stanford University, CA; 2Department of  Electrical Engineering, 
Biomedical Engineering, Technical University of  Denmark, Lyngby, Denmark; 3Department of  Clinical Neurophysiology, Danish Center for Sleep Medicine, Rigshospitalet, 
Copenhagen, Denmark; 4Department of  Population Health Sciences, School of  Medicine and Public Health, University of  Wisconsin-Madison, WI
Study Objectives: To determine whether defining two subtypes of  sleep-disordered breathing (SDB) events—with or without hypoxia—results in measures that 
are more strongly associated with hypertension and sleepiness.
Methods: A total of  1 022 participants with 2 112 nocturnal polysomnograms from the Wisconsin Sleep Cohort were analyzed with our automated algorithm, 
developed to detect breathing disturbances and desaturations. Breathing events were time-locked to desaturations, resulting in two indices—desaturating 
(hypoxia-breathing disturbance index [H-BDI]) and nondesaturating (nonhypoxia-breathing disturbance index [NH-BDI]) events—regardless of  arousals. 
Measures of  subjective (Epworth Sleepiness Scale) and objective (2 981 multiple sleep latency tests from a subset of  865 participants) sleepiness were 
analyzed, in addition to clinically relevant clinicodemographic variables. Hypertension was defined as BP ≥ 140/90 or antihypertensive use.
Results: H-BDI, but not NH-BDI, correlated strongly with SDB severity indices that included hypoxia (r ≥ 0.89, p ≤ .001 with 3% oxygen-desaturation index 
[ODI] and apnea hypopnea index with 4% desaturations). A doubling of  desaturation-associated events was associated with hypertension prevalence, which 
was significant for ODI but not H-BDI (3% ODI OR = 1.06, 95% CI = 1.00–1.12, p < .05; H-BDI OR 1.04, 95% CI = 0.98–1.10) and daytime sleepiness (β = 0.20 
Epworth Sleepiness Scale [ESS] score, p < .0001; β = −0.20 minutes in MSL on multiple sleep latency test [MSLT], p < .01). Independently, nondesaturating 
event doubling was associated with more objective sleepiness (β = −0.52 minutes in MSL on MSLT, p < .001), but had less association with subjective sleepiness 
(β = 0.12 ESS score, p = .10). In longitudinal analyses, baseline nondesaturating events were associated with worsening of  H-BDI over a 4-year follow-up, 
suggesting evolution in severity.
Conclusions: In SDB, nondesaturating events are independently associated with objective daytime sleepiness, beyond the effect of  desaturating events.
Keywords: Pattern recognition, automated, Outcome Assessment (Health Care), sleep apnea syndromes.
INTRODUCTION
The most common manifestation of sleep-disordered breathing 
(SDB), obstructive sleep apnea (OSA), affects approximately 
one-fourth of men and approximately one-tenth of women.1 
With recent increases in obesity, OSA prevalence has increased 
14%–55% over the last 2 decades, resulting in millions of 
untreated individuals.1,2 Health consequences of OSA range 
from increased all-cause mortality, cardiovascular morbidity, 
psychiatric illness, traffic accidents, and lost productivity.3,4
The apnea hypopnea index (AHI)-based definition of OSA 
has changed over time and is inconsistently applied, making 
the clinical impact of sleep-disordered breathing difficult to 
interpret. Because cardiovascular consequences have been 
associated with oxygen desaturation, Medicare criteria man-
date that hypopneas include ≥4% oxyhemoglobin desaturation. 
However, many participants—especially the young, nonobese, 
and women—have SDB without desaturations.5 Reflecting this, 
the most recent American Academy of Sleep Medicine (AASM) 
recommendations define hypopneas by association with either 
arousal or ≥3% desaturation.6 The Medicare and AASM 2007 
standard criteria for scoring OSA events result in substantially 
different prevalence rates at equivalent frequency cutoffs.7,8 
Even individuals with the same AHI have vast differences in 
SDB characteristics.9,10 Recent studies have highlighted that the 
oxygen-desaturation index (ODI)11 or event duration9,12 may be 
more predictive of cardiovascular outcomes.
Similarly, daytime sleepiness is an important symptom of 
OSA, imparting a significant psychosocial burden.3,4 Yet, 
large epidemiologic studies have found only 35% of partici-
pants with moderate OSA and 37% with severe OSA reported 
excessive daytime sleepiness, the cardinal daytime symptom of 
OSA.13In a comparison among OSA, upper airway resistance 
syndrome (UARS), and controls, the subjective and objective 
measures of sleepiness were worse in the participants, com-
pared with controls.14 However, there were no appreciable dif-
ferences in sleepiness measures between the participant groups 
Statement of Significance 
This study objectively verified the clinical importance of nondesaturating sleep-disordered breathing events through a popu-
lation-based sample (the Wisconsin Sleep Cohort [WSC]). Using AASM guidelines, an automated sleep-disordered breathing 
(SDB) scoring algorithm identified flow-reducing breathing events, with and without oxygen desaturations. Different breath-
ing disturbance indices (desaturating and nondesaturating) are associated with different clinical outcomes. Consistent with 
current evidence, oxygen-desaturating breathing disturbances were associated with prevalent hypertension and sleepiness. 
Nondesaturating events were associated only with objective sleepiness, for the first time objectively confirming clinical prac-
tice. Longitudinal models pointed to conversion from nondesaturating to desaturating breathing events over 4-year follow-up. 
Together the data suggest that nondesaturating breathing disturbances are a milder SDB phenotype, warranting further investi-
gation into their pathophysiology and optimal treatments.
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(OSA and UARS).14Furthermore, both groups had similar 
rates of breathing disturbances (RDI for UARS and AHI for 
OSA), suggesting that the chronicity of the breathing problem 
in participants with OSA may result in a blunting of the arousal 
response (as measured by visually scored and electroencepha-
logram [EEG] spectral power changes), fundamentally chang-
ing the nature and pathophysiology of the events comprising 
the indices as disease severity progresses. This hypothesis has 
found support in the blunted canine arousal responses to airway 
occlusion resulting from sleep fragmentation or sleep apnea,15,16 
as well as in AHI increases caused by sleep fragmentation in 
humans.17 Moreover, despite normal nocturnal oxygenation, 
participants with snoring18,19 and UARS20 have shown improve-
ments in daytime function with continuous positive airway 
pressure (CPAP). And when hypoxemia was experimentally 
induced despite sleep breathing improvement with CPAP, the 
improvement in MSL was no different from CPAP usage with 
normoxia, pointing to a nondesaturating mechanism causing 
objective sleepiness.21 Taken together, these findings highlight 
that data-driven polysomnographic analyses could lead to bet-
ter understanding of the different pathophysiologies like OSA 
and their consequences.
Additionally, a major obstacle to OSA treatment is poor 
adherence to gold-standard therapy: CPAP. Despite dose-re-
sponse symptomatic improvements with usage, compliance is 
unpredictable22 and correlates weakly with AHI, cardiovascular 
morbidity, and sleepiness.23,24 Even clinical outcomes are hard 
to confirm as trial results show weak effects of CPAP on blood 
pressure, metabolic derangements, inflammation, and obesity.25 
This also may relate to the difficulty of assessing disease sever-
ity with a single metric: the AHI.26,27
There are complex anatomical and physiological interactions 
that contribute to OSA, such as upper airway fat deposition 
and anatomy, muscle control, loop gain, and arousal threshold 
variations.28–33 Because different pathophysiologic mechanisms 
presumably result in different consequences of breathing dis-
turbances, and these different types of breathing disturbances 
may result in different clinical outcomes, the aim of the current 
study was to use an automated breathing-disturbance detection 
algorithm to differentiate breathing events (eg, with desatu-
ration or not) in order to ascertain differences in clinical out-
comes (eg, sleepiness and hypertension) associated with these 
distinct breathing event types.
METHODS
Population and Sample
The University of Wisconsin-Madison Health Sciences and 
Stanford University Institutional Review Boards approved 
the study (Stanford #19027; University of Wisconsin 2012-
0084). Protocols for the WSC Study have been described pre-
viously.34 Briefly, in 1988, all employees of five state agencies 
in Wisconsin, aged 30–60 years, were mailed a survey about 
sleep habits, health, and demographic characteristics. Initial 
response rate was 73% (5 091/6 947). Invitation to participate 
in overnight polysomnography (PSG) (repeated every 4 years) 
was extended to a stratified random sample of 2 884 individuals 
(nonpregnant and without recent airway cancer, airway surgery, 
or decompensated cardiopulmonary disease). Of these, 1 545 
agreed to participate in at least one overnight protocol. For this 
analysis, there were 1 022 eligible participants from the cohort 
that provided computer-recorded sleep studies. The majority of 
participants underwent at least two (maximum six) sleep stud-
ies, all of which were used for this analysis.
Two multiple sleep latency test (MSLT) protocols were con-
ducted between June 1989 and August 2003: a research pro-
tocol (1 839 studies) was conducted for an average of 3 weeks 
after PSG and a clinical protocol (1 142 studies) was conducted 
in the morning following PSG. In both protocols, participants 
completed a week-long sleep diary and went to bed at their 
sleep-diary-based habitual bedtime on the night prior to test-
ing. Both MSLT protocols were conducted in accordance with 
established practice parameters35,36 modified as follows: (1) all 
participants proceeded with the MSLT, even if total sleep time 
on the preceding night was <6 hours; (2) all participants contin-
ued medications, without change, before or during the MSLT; 
(3) clinical protocol participants began the MSLT 1.5 hours 
after awakening from overnight PSG and were allowed to sleep 
for 15 minutes of clock time after sleep onset in a nap period; 
(4) research protocol participants began the MSLT at 10:00 and 
were awakened immediately and the nap trial ended immedi-
ately after sleep onset was established.
Measurements
Sleep studies were performed at the Clinical Research Unit of 
the University of Wisconsin. Sleep studies included PSG and 
other assessments, including blood pressure and body mass 
index (BMI). At each polysomnography study, hypertension 
was defined by one of the two methods: clinically assessed 
auscultatory blood pressure equal to or above 140/90 mm Hg 
(measured as described in Ref.37) or use of antihypertensive 
medications (“clinical hypertension”). Data on medical his-
tory, medication use, alcohol use, smoking habits, depression, 
and self-reported sleep habits, problems, and daytime sleepi-
ness were obtained using questionnaires. Subjective daytime 
sleepiness was assessed using the Epworth Sleepiness Scale 
(ESS), which asks participants to rate their likelihood of falling 
asleep in a variety of common situations and assigns a score 
from 0 (least sleepy) to 24 (sleepiest), with the commonly 
defined threshold for daytime sleepiness set at a cutoff of >10.36 
Objective daytime sleepiness was assessed using the MSLT, 
which allows for 4–5, 20-minute nap periods to determine 
whether there is rapid sleep onset (MSL <8 minutes) and/or 
the presence of sleep-onset rapid eye movement (REM) periods 
(REM sleep onset <15 minutes in a nap period).36 Depression 
was assessed by either a Zung score of ≥5038 or antidepressant 
use. Insomnia was defined as a habitual sleep mean <6 hours 
per night based on the weeklong sleep diaries completed by 
participants prior to the MSLT.
Sleep state and respiratory/cardiac parameters were assessed 
with polysomnography (Grass Instruments, Quincy, MA, 
USA). Each 30-second epoch of the polysomnographic records 
was scored for sleep stage by trained sleep technicians, using 
conventional criteria incorporating electroencephalography, 
electrooculography, and electromyography.39 Oxyhemoglobin 
saturation was recorded using a photoplethysmograph (Ohmeda 
3740, Englewood, CO, USA). Oral airflow was recorded using a 
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thermocouple (ProTec, Hendersonville, TN, USA). Air pressure 
at the nares was recorded using a pressure transducer (Validyne 
Engineering Corp., Northridge, CA, USA). Chest and abdomen 
excursions were recorded using respiratory inductance plethys-
mography (Respitrace, Ambulatory Monitoring, Ardsley, NY, 
USA).
Detection of Desaturation Events
The photoplethysmograph hemoglobin saturation (SaO
2
) signal 
was used for desaturation detection. Initially, the saturation sig-
nal was down-sampled to 100 Hz, and fluctuations due to the 
signal’s discrete values were minimized by smoothing the sig-
nal with a moving average window of 2 seconds (25% overlap) 
(Supplementary Figure S1). Signal was limited to the 5th–95th 
percentiles, to eliminate extreme peaks. The algorithm was 
optimized on PSGs using the manually scored, ≥3%-desatu-
ration criterion. Local maxima were detected and subsequent 
drops of >2% lasting >4 seconds were identified as desaturation 
events, based on this algorithm optimization (Supplementary 
Figure S2). Also, based on optimization, transient increases of 
0.4% during an event were allowed. Resaturation was detected 
using a similar strategy. Fivefold cross-validation on 40 ran-
domly selected participants (10 PSGs from each subgroup: 
AHI < 5, AHI 5–15, AHI 15–30, AHI > 30) demonstrated good 
desaturation algorithm performance in all standard measures of 
model robustness40 using the desaturation/resaturation parame-
ters outlined above:
•
 
Precision 
positive predictive value  ( ) = true positives
true
.
positives false positives+
=  970
•
 
Recall sensitivity  ( ) =
+
true positives
true positives false negatives
.=  730
• Classification accuracy as measured by F score − = 2* precision recall
precision recall
*
.
+
=  830
Artifact Removal
Nasal pressure (NP), airflow thermocouple (oral flow), and 
chest/abdomen respiratory inductance plethysmography (RIP) 
belts were used in the detection of stable and reduced breathing. 
NP signals were removed with hardcoded thresholds to elimi-
nate out-of-bound signals and periods with lack of pressure sig-
nal (suggesting cannula dislodgement), based on trial-and-error 
optimization with 80 randomly selected PSGs. Fast Fourier 
transform, spectral power comparisons between high and low 
frequencies allowed for removal of artifacts caused by loud 
snoring (a high-frequency artifact) on low-flow breathing.
Detection of Nasal Pressure Drops
RIP belts were bandpass filtered from 0.1–5 Hz. Five-minute 
windows (50% overlap) were evaluated for NP maxima/min-
ima as well as start of inspiration and expiration, based on sig-
nal zero-crossing. NP and RIP signals were aligned (with the 
chest belt taking priority in cases of paradoxical breathing) to 
check the NP signal and calculate breathing frequency. After 
correction for inverted signals, NP maximum (NP
max
) and min-
imum (NP
min
) values were detected from the nontransformed 
signal, based on inspiratory peaks and expiratory troughs, 
respectively. Outliers beyond the 5th–95th percentile range 
were eliminated and a moving 1-minute averaging window, 
which assigns low weight to outliers, was applied to establish 
a baseline not impacted by artifacts. Using the AASM 2012 
standard,6 when compared with the baseline, if there was a 
>30% decrease in NP amplitude (NP
max
–NP
min
) of breaths over 
>10 second period, without a commensurate twofold increase 
in oral breathing, then an event was scored (Supplementary 
Figure S3). Exclusion of rare central events was based on RIP 
belt activity that dropped below 75% baseline amplitude for 
>50% of event. These calculations resulted in a breathing dis-
turbance index (BDI) for each participant, independent of asso-
ciated arousal or hypoxia events.
Event Linking
All signals were cleaned by either an artifact detection algorithm or 
digital filtration. If more than 75% of the recording was contami-
nated with artifacts, the signal was excluded from further analysis. 
Desaturation events were time-locked to NP drops if there was an 
overlap of the NP event with the 10 seconds preceding or follow-
ing the start of the desaturation. Events that could be linked to a 
2% desaturation comprised the hypoxia-BDI (H-BDI), others the 
nonhypoxia-BDI (NH-BDI) (Figure 1). The focus on nonassoci-
ated breathing disturbances was intentional: allowing exploration 
of the potential clinical associations of the breathing disturbances 
themselves (particularly those that may not manifest with an EEG 
arousal or desaturation) and avoiding variability in scoring of asso-
ciated polysomnographic phenomena (ie, EEG arousals).
Statistical Analysis
Analyses were performed with SAS software v9.4 (SAS 
Institute Inc., Cary, NC, USA). Indices were log
2
-transformed 
to enhance model fit. Group means were compared using two-
tailed t-tests with the assumption of unequal variances between 
groups. A threshold of 0.05 was used to minimize type I error; 
however, the p-value was used in combination with effect sizes 
and alternate methods of analysis to ensure the validity of find-
ings. Pearson product moments were used to assess linear cor-
relations between indices. Generalized estimating equations 
(for binary outcomes) and mixed modeling (for continuous 
outcomes) were used to estimate robust standard errors for sig-
nificance testing, allowing for incorporation of repeated meas-
ures into analyses. Odds ratios were calculated from logistic 
regression to assess association with prevalent hypertension 
(dichotomous). Linear regression was used to determine the 
associated degree of subjective (ESS score) and objective (MSL 
on MSLT) sleepiness. Finally, a generalized linear model was 
used to assess the associated change in 3% ODI over a 4-year 
follow-up period.
RESULTS
The total sample was comprised of 1 022 unique individu-
als, with 2 112 sleep studies. Age (59.7 ± 8 vs 58.9 ± 8) and 
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proportion of men (53% vs 52%) were not different between the 
entire sample and the subset who underwent MSLT (n = 865); 
other variables of interest were similar between the groups 
(Supplementary Table S1). Table 1 indicates that H-BDI has 
strong correlation with all traditional measures of OSA sever-
ity: ODI with 3% desaturation threshold and AHI with 4% 
hypopnea criteria (Supplementary Figure S4). Suggesting that 
it is an independent measure of SDB, NH-BDI showed no cor-
relation with any of the traditional OSA metrics. This explains 
the weakening of correlations noted in the BDI (a combined 
measure of H-BDI and NH-BDI) compared with H-BDI alone. 
Pairwise comparisons between each of the breathing distur-
bance indices further highlight the distinction between H-BDI 
and NH-BDI based on mean event duration (62.8 ± 11 vs 
25.6 ± 5, p < .05) (Figure 1).
The relationship of SDB severity to hypertension has been 
assessed in this longitudinal cohort before, indicating that 
a threshold of five events per hour for desaturating events 
(H-BDI) is most appropriate, given the high correlation with 
the measure initially used to establish this association: AHI 
with 4% desaturations (AHI 4).41,42 Moreover, because desat-
urating sleep-disordered breathing events are generally con-
sidered more severe, qualifying individuals for a diagnosis 
of OSA according to all accepted guidelines, a cutoff of five 
events per hour was felt to be appropriate in this study for com-
paring groups by the H-BDI, whereas a more conservative cut-
off of 15 events per hour was used for NH-BDI stratification, 
due to independence of the index from the desaturating events 
and a lack of identified consequences (ie, arousal), through our 
algorithm. Stratification revealed age, BMI, the presence of 
snoring, and neck girth were significantly associated with more 
frequent desaturations, regardless of NH-BDI level (Table 2, 
and Supplementary Tables S2 and S3). Additionally, the high 
H-BDI group was subjectively sleepier, despite no objective 
evidence of increased sleep propensity on MSLT. The prev-
alence of hypertension was higher in the H-BDI > 5 group. 
Individuals with either an H-BDI > 5 or an NH-BDI > 15 were 
more likely to be male. Moreover, those with high NH-BDI 
(>15) in addition to a high H-BDI (>5) were more likely to be 
males than those with just an elevated H-BDI.
Odds ratios were calculated to determine the increased odds 
of hypertension based on severity of sleep-disordered-breathing 
events, as measured by various indices (Table 3). After correc-
tion for age, sex, BMI, alcohol consumption, and smoking sta-
tus, only the log
2
-transformed 3% ODI was associated with a 
mildly increased risk of hypertension (OR = 1.06, 95% CI 1.00–
1.12, p < .05). While in the correct direction (OR = 1.04, 95% CI 
0.98–1.12, p = .19), the H-BDI did not reach statistical signifi-
cance in association with prevalent hypertension, probably due 
to the more liberal 2% desaturation used to define the measure. 
Conversely, a stronger association with objective sleepiness was 
noted in the nondesaturating events (NH-BDI), with a half min-
ute shorter MSL for every doubling of the nondesaturating event 
rate (β = −0.52 minutes MSL per doubling of event rate, 95% 
CI −0.81 to −0.23, p = .004). The NH-BDI contributed most sig-
nificantly to the strong objective and subjective sleepiness asso-
ciations with BDI, with beta coefficients in the linear models 
suggesting a 0.39- (0.20–0.57, p < .0001) point increase in the 
ESS and 0.73- (0.44–1.03, p < .0001) minute decrease in MSL 
on MSLT for every doubling of the BDI (Table 4). A similar, 
but weaker, association was found for the desaturation-associ-
ated breathing events (ie, 3% ODI and H-BDI).
Figure 1—Demonstration of  algorithm-tagged events. Two 120-second epochs of  sleep from the same individual, demonstrating (A) two 
desaturation-associated breathing disturbances (contributing to H-BDI) and (B) one nondesaturating breathing disturbance (contributing to 
NH-BDI).
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In order to determine whether NH-BDI represented a less 
severe form of sleep-disordered breathing, a general linear 
model was used to assess the associated change in H-BDI 
over a 4-year time interval (ΔH-BDI) in the 654 individuals 
with follow-up sleep studies. The model incorporated com-
monly associated clinical variables, including baseline BMI, 
age, sex, alcohol consumption (number of drinks), smoking 
status (current, never, previous), neck girth, log
2
-transformed 
NH-BDI, log
2
-transformed H-BDI baseline, and the change in 
BMI over the same time period (added in order to account for 
the known effect of BMI on desaturating event rate8,43). Age, 
alcohol consumption, and NH-BDI were the only significant 
baseline factors, with NH-BDI β-coefficient = 1.96, indicating 
an estimated, co-variate adjusted 4-year increase in the H-BDI 
of nearly two events per hour for every doubling of baseline 
NH-BDI, p = .0002. Expectedly, the change in BMI (β = 1.14 
events/hour for every unit increase in BMI, p < .0001) had a 
strong influence on ΔH-BDI (Table 5).
DISCUSSION
Automated scoring provides a means by which SDB events 
can be consistently scored, without the inter-/intra-rater vari-
ability of human scorers. The scoring algorithm of the present 
study identified breathing disturbances with (H-BDI or ODI) 
and without (NH-BDI) associated oxyhemoglobin desatura-
tions. Indeed, H-BDI correlated strongly with ODI measures 
and the Medicare AHI 4% (Table 1), indicating this index 
adequately reflects hypopneas and apneas with desaturations. 
In contrast, the NH-BDI did not correlate with these meas-
ures, indicating that it reflects a distinct entity from desatura-
tion-based sleep-disordered breathing (Table 1, Figure 2, and 
Supplementary Figure S4). As both indices independently 
Table 1—Correlations of  Variables of  Interest After log2-transformation.
Mean (SD) Correlation coefficient
AHI 4 ODI3 BDI H-BDI NH-BID
AHI 4 2.7 (2.1) × 0.94* 0.70* 0.89a 0.002b
ODI 3 2.7 (2.0) × × 0.69* 0.90* −0.04b
BDI 4.5 (0.9) × × × 0.81* 0.52*
H-BDI 2.7 (1.9) × × × × 0.10a
NH- BDI 3.7 (0.8) × × × × ×
Using the last visit for each participant; n = 1 022. *p < .0001, ap = .001, bnot significant. Abbreviations: AHI 4 = 4%-hypopnea-criterion apnea-hypopnea 
index; ODI3 –=3% desaturation ODI criterion; BDI = total breathing disturbance index; H-BDI = breathing disturbance index with associated oxygen desatu-
rations; NH-BDI = breathing disturbance index without associated oxygen desaturations.
Table 2—Characteristics of  H-BDI and NH-BDI Stratifications.
Low H-BDI (< 5) High H-BDI (>5)
Low NH-BDI (<15) High NH-BDI (≥15) Low NH-BDI (<15) High NH-BDI (≥15)
N 526 252 598 736
Age, years, mean (SD) 57.6 (9) 59.0 (9)* 59.7 (8)*,a 61.3 (8)*,a
Body mass index, kg/m2, mean (SD) 28.3 (6) 27.4 (5) 34.0 (7)*,a 31.8 (6)*,a
MSLT, minutes, mean (SD) 12.3 (5) 11.7 (5) 11.7 (5) 11.2 (5)*
Epworth, mean (SD) 7.8 (4) 8.1 (4) 9.1 (4)*,a 9.0 (4)*,a
Number of  alcoholic drinks per week, mean (SD) 3.3 (5) 3.6 (5) 3.6 (5) 4.2 (6)
Neckgirth, centimeters, mean (SD) 36.3 (4) 36.6 (3) 39.6 (4)*,a 39.4 (4)*,a
Male, n (%) 193 (37) 133 (53)* 325 (54)* 475 (65)*,a,b
Hypertension, n (%) 210 (40) 96 (38) 369 (62)*,a 426 (58)*,a
Current smoker, n (%) 63 (12) 30 (12) 61 (10) 45 (6)*,a,b
Depression, n (%) 148 (28) 64 (25) 176 (30) 171 (23)
Frequent snoring, n (%) 134 (28) 71 (34) 307 (58)*,a 391 (60)*,a
Insomnia, n (%) 264 (50) 131 (52) 299 (50) 366 (50)
*p < .05, significantly different from low H-BDI/low NH-BDI group; ap < .05, significantly different from low H-BDI/high NH-BDI group; bp < .05, significantly 
different from high H-BDI/low NH-BDI group.
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correlated with objective daytime sleepiness, as measured with 
the MSLT (Table 4), it is probably both types of events that 
disturb sleep and, although this was not verified in this study, 
induce significant EEG or subcortical arousals that disrupt 
sleep. Alternatively, the associated sleepiness may reflect a 
characteristic of an underlying sleep disturbance that predis-
poses to sleep-disordered breathing.
This is consistent with the suggested associations in the liter-
ature. Although Martin and colleagues found that arousals cor-
related with MSL, no relationship was found between arousals 
and ESS in participants with OSA.44 However, contrary to our 
findings, the AHI was most strongly associated with changes in 
MSL.44 Similar to our findings, work by Roehrs and colleagues 
showed that arousal indices were more significantly correlated 
with MSL than hypoxic measures; again this was in a clini-
cal population of participants with OSA.45 Nonetheless, their 
results suggest that sleep fragmentation accounts for about 16% 
of the variance in daytime sleepiness.45 Additionally, many par-
ticipants with OSA have a similar number of cortical arous-
als as normal participants when studied in a sleep laboratory;46 
thus, it does not appear to be the cortical arousals that are the 
cause of the increased sleepiness, per se. It is also important to 
note that many of these studies have explored arousal events 
that have a significant overlap with desaturating breathing dis-
turbances, suggesting a high degree of collinearity among the 
measures studied in the existing literature.47 Furthermore, not 
all sleep-related apneas and hypopneas are terminated by corti-
cal arousals, and thus, our efforts to identify the clinical impact 
of non-desaturating sleep breathing disturbances—regardless 
of the polysomnographic associations—highlight the value of 
incorporating these events into indices, in addition to suggesting 
a need for further exploration of their pathophysiologic basis.
Of interest was the comparison of participants with high ver-
sus low NH-BDI, and high versus low desaturating indices (eg, 
H-BDI) (Table 2). Older participants and men are known to 
have more severe SDB,5 a phenomenon reflected here by the 
fact that older individuals and a higher percentage of men had 
both higher H-BDI and NH-BDI. Although participants with 
high NH-BDI were more likely to be older and male (regard-
less of H-BDI), it was those individuals with high H-BDI (vs 
low H-BDI) that had slightly higher BMIs, concordant with the 
findings that increased weight is associated with a desaturat-
ing sleep-disordered breathing.8,43 This relationship was also 
supported by our longitudinal model (Table 5), as increases in 
desaturations after 4-year follow-up (ΔH-BDI) were not only 
associated with baseline H-BDI, age, and BMI, but also by 
baseline frequency of nondesaturating events (NH-BDI) and 
changes in BMI that have occurred over 4 years (ΔBMI). The 
fact that participants with higher H-BDI are generally more 
obese and have greater neck girth8,43 is also in agreement with 
our observation that increased body weight contributes to the 
emergence of desaturating breathing disturbances. Breathing 
disturbances associated with oxygen drops (H-BDI) were also 
significantly longer in duration (Figure 1) suggesting that with 
time and increased BMI, participants may be less arousable, 
leading to longer, more severe pauses that have time to pro-
duce significant desaturations. Other contributors could involve 
a higher prevalence of pulmonary or hematologic (eg, anemia) 
pathology with age and increased BMI.
Hypertension was substantially more prevalent (60% vs 39%) 
in individuals with high H-BDI compared with those with low 
ODI, a trend that was not observed in relation to nondesatu-
rating breathing disturbances (high NH-BDI vs low NH-BDI: 
53% vs 52%). Logistic regression models (Table 3) confirmed 
the association of oxygen-desaturation events with the odds of 
hypertension: a doubling of the ODI 3% was significantly asso-
ciated with 6% increased odds of prevalent hypertension (OR 
1.06, 95% CI 1.00–1.12, p < .05). A weaker relationship was 
Table 4—Relationship of  log2-transformed Breathing Variables With Subjective and Objective Sleepiness.
Model parameters (for a twofold change in breathing disturbance indices)
Epworth Sleepiness Scalea MSLb
Beta 
Coefficient
95% confidence 
interval
p-Value Beta coefficient 95% confidence interval p-Value
ODI 3% 0.20 (0.11, 0.29) <.0001 −0.17 (−0.31, −0.04) .0146
NH-BDI 0.12 (−0.03, 0.27) .1043 −0.52 (−0.81, −0.23) .0004
H-BDI 0.20 (0.11, 0.30) <.0001 −0.20 (−0.35, −0.05) .0086
BDI 0.39 (0.20, 0.57) <.0001 −0.73 (−1.03, −0.44) <.0001
Adjusted for aage, sex, body mass index, habitual sleep, depression; bage, body mass index, sex, habitual sleep duration, sleep efficiency, minutes of  sleep 
the two nights preceding clinical MSLT.
Table 3—Relationship of  log2-transformed Breathing Variables With 
Hypertension.
Model parameters for hypertension* (for a twofold 
change in breathing disturbance indices)
Odds 
ratio
95% confidence 
interval
p-Value
ODI 3% 1.06 (1.00, 1.12) .0496
BDI 0.98 (0.85, 1.12) .7287
H-BDI 1.04 (0.98, 1.10) .1931
NH-BDI 0.93 (0.83, 1.05) .2439
*Adjusted for age, sex, body mass index, smoking, alcohol.
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found with H-BDI (OR 1.04, 95% CI 0.98–1.10, p = .19), pre-
sumably due to the use of a 2% desaturation threshold to define 
the index. These findings are in accord with prior animal and 
human work that points to higher cardiovascular risk mostly 
with oxygen desaturations (typically 4%) and not sleep distrup-
tions.11,48,49 Moreover, studies of multiple polysomnographic 
parameters have similarly found strong primary associations 
between duration of sleep with low blood oxygen levels and 
cardiovascular risk.50,51 The mechanistic links to cardiovascular 
risk appear to be mediated by oxidative stress, systemic inflam-
mation, and endothelial dysfunction in the setting of chronic, 
intermittent hypoxia.52
A different picture emerged with regard to the relationship of 
these indices with daytime sleepiness. As expected, participants 
with H-BDI > 5 were subjectively (ESS: 9.0 ± 4 vs 7.9 ± 4) 
sleepier (Supplementary Table S2) regardless of the severity of 
NH-BDI, though they were not found to be objectively sleepier 
on MSLT. In fact, it was only individuals with both high NH-BDI 
and ODI who had significantly lower MSL on the MSLT com-
pared with the “normal” group with low ODI and low NH-BDI 
(11.2 ± 5 vs 12.3 ± 5 minutes). This was also confirmed by our 
multivariate model (Table 4, Figure 3), which showed strong 
associations of nondesaturating events with objectively meas-
ured daytime sleepiness (MSLT). Essentially, for every dou-
bling of the NH-BDI, there was a >30-second decrease in MSL 
(Figure 3). Interestingly, associations of nondesaturating events 
with subjective sleepiness were more variable and nonsignif-
icant (although trending toward significance), suggesting that 
sleep disruptions caused by the breathing disturbances above 
and beyond the desaturation-associated events are associated 
with objective daytime sleepiness, and that desaturations have a 
greater effect on subjective daytime sleepiness. These findings 
suggest that sleep fragmentation or another feature of sleep-dis-
ordered breathing not captured by the AHI (or ODI) and not 
hypoxia explains, in part, objective and subjective sleepiness, 
particularly given that the current algorithm did not differen-
tiate desaturating events with arousals from those without.45,53
Prior studies have explored these questions through the 
impact of sleep fragmentation. Significant decreases in MSL 
have been noted after nonvisible sleep fragmentation, with no 
difference in subjective daytime sleepiness as measured by the 
Stanford Sleepiness Scale.53 This is in line with the reported 
discordance between subjective and objective sleepiness meas-
ures,54,55 and our findings. In fact, more recent studies of OSA 
populations have suggested that desaturating events appear to 
correlate with subjective,56 but not objective, sleepiness.55 The 
correlation between sleep fragmentation measures and daytime 
Table 5—General Linear Model of  Change in H-BDI Over a 4-Year Follow-up.
Parameter Estimate Standard error t value Pr > |t|
Age −0.10 0.05 −2.00 0.0455
log2(NH-BDI) 1.96 0.52 3.74 0.0002
log2(H-BDI) −1.02 0.23 −4.44 <0.0001
ΔBMI 0.97 0.17 5.68 <0.0001
R2 = 0.104817
df = 10
F = 7.53
Root MSE = 9.133602
Change in H-BDI, 2.50 ± 9.58 events/hour. Model corrected for baseline BMI, age, sex (binary), number of  alcoholic drinks per week, smoking status 
(categorical: current, never, past), neck girth, and log2-transformed H-BDI, as well as change in BMI over the same 4-year follow-up. Abbreviations: 
ΔBMI = change in BMI from baseline.
Figure  2—Participants’ mean event duration, stratified by index. 
Boxplot of  event durations with central line demonstrating mean 
of  individual means, the box ends demonstrating 2 SD around the 
mean, and the whiskers demonstrating range of  individual means. 
All pairwise comparisons between indices were significantly dif-
ferent, p < .05. Abbreviations: BDI = breathing disturbance index, 
H-BDI  =  desaturation-associated breathing disturbance index, 
NH-BDI = nondesaturation-associated breathing disturbance index.
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sleepiness frequently accounts for only a small part of the total 
variance,47 which is why we initially sought to explore nonde-
saturating breathing disturbances, regardless of association, as 
a means of determining whether the sleep-breathing events, in 
and of themselves, justify their inclusion into the AHI. The lack 
of correlation of the NH-BDI with any other traditional meas-
ure of SDB in this population-based sample suggests that the 
events in question are truly distinct from the standard measures 
of SDB studied in the literature to date. Our results prompt fur-
ther investigations into the mechanisms by which the breathing 
disturbances are associated with objective sleepiness, whether 
it is through EEG/autonomic arousals or other, potentially bidi-
rectional, pathophysiologic processes.
Additionally, snoring appeared to be more common among 
individuals with an H-BDI > 5 compared with those <5 (59% 
vs 30%, p < .05). However, upon comparing NH-BDI <15 with 
≥15 (53% vs 44%, p < .05), it was revealed that snoring is more 
prevalent regardless of the metric used to define SDB severity, 
proving it to be a poor differentiator. Similarly, insomnia and 
depression showed no major differences between any subgroup.
There are a number of limitations to the current method, which 
will be improved upon in future projects. The most evident is 
the usage of hard-coded algorithms that rely upon existing scor-
ing standards, which will likely continue to evolve as our under-
standing of sleep-disordered breathing grows. Additionally, the 
NH-BDI was defined as all nondesaturating breathing distur-
bances; however, detection of other specific consequences 
such as cortical or autonomic arousals and increased effort of 
breathing and flow limitations may help delineate the breathing 
events more effectively. Similarly, arousal-associated desaturat-
ing events were not differentiated from nonarousal associated 
events, which will be addressed with future scoring algorithms. 
Furthermore, in order to ensure high quality of the NP signal, 
large amounts of data were excluded due to artifacts (eg, periods 
with severe snoring in combination with low amplitude NP), but 
such phenomena are hallmarks of OSA in certain participants. 
Another limitation is that the findings may not be generalizable 
beyond the WSC, a middle-to-older-aged, predominantly white 
sample with relatively few leanparticipants. Fortunately, soft-
ware-based algorithms can easily be applied to new cohorts for 
future verification of their validity and reliability.
To the best of our knowledge, this is the first study that has 
differentiated desaturating and nondesaturating SDB events 
in a population-based sample, in order to identify differen-
tial associations with cross-sectional and longitudinal clinical 
outcomes. This was possible through a hard-coded automated 
scoring algorithm that could reproducibly quantify all breathing 
disturbances, regardless of association, allowing for time-lock-
ing of breathing disturbances to automatically scored desatura-
tion events. Future studies can further differentiate the subtypes 
of breathing disturbances, based on their polysomnographic 
associations, in order to more precisely phenotype sleep-dis-
ordered breathing. Subphenotypes may offer insights into the 
pathobiology of sleep-disordered breathing, thereby resulting in 
optimization of therapeutic choice(s) and clearer associations to 
clinical outcomes.
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